The sympathetic nervous system is important in the control of heart rate and myocardial contractility (1 8). The stimulatory actions of catecholamines on cardiac tissue are primarily, but not exclusively, mediated via P-AR. These, in turn, regulate myocardial and heart rate responses to exogenous and endogenous stimuli through adenylate cyclase [ATP pyrophosphatelyase (cyclizing), EC 4.6.1.11. This enzyme catalyzes the synthesis of 3',5'-cyclic adenosine monophosphate, which acts as a second messenger ( 17, 26) .
The interaction between the sympathetic nervous system and myocardial performance in fetuses and neonates has been extensively studied in several animal species (chick, rat, guinea pig, mouse, sheep, rabbit). Using well established in vivo and in vitro physiological and pharmacological methods, studies have suggested that there is a progressive increase in the ability of fetal myocardium to respond to exogenous and endogenous catecholamine stimuli with advancing gestation (1, 5, 7, 9, 10, 20, 2 1, 28, 29).
Potential causes for this improvement in myocardial perform-ance could include a quantitative or qualitative change in one of the components of the P-adrenoreceptorladenylate cyclase complex. With the advent of in vitro radioreceptor methodology and availability of sensitive enzymatic assays, it has become possible to study the molecular biology of this complex both in adult and fetal myocardia. We recently reported on the ontogenesis of Padrenergic receptors in fetal rabbit myocardium using '251-HYP, a specific P-adrenergic receptor antagonist, as the radioligand. We found that there was a progressive increase in the density of P-adrenoreceptors with advancing gestation but no significant change in their affinity for IZ5I-HYP or unlabeled P-AR-specific agonists and antagonists (1 1). Similar results have been reported by other investigators in some animal species (5) but not in others (2, 6, 33) . Adenylate cyclase activity in adult myocardial tissue has been studied in detail in several animal species (6, 8, 13-15, 23, 24, 27, 30) . However, there is significantly less information available about myocardial adenylate cyclase activity in fetal and neonatal animals. While some studies have suggested that there is a progressive increase in basal adenylate cyclase activity and per cent stimulation above baseline, others have not fully confirmed these results (3, 6, 16, 23, 30) . Recently, Schumacher and coworkers (23) reported on adenylate cyclase characteristics from pooled (not individual) 27-day gestation fetal, neonatal, and adult rabbit hearts and concluded that there was a progressive increase in the ability of the enzyme to respond maximally to high doses of I-isoproterenol from fetus and neonate to adult while the opposite was seen when half-maximal effective concentration of I-isoproterenol was determined. However, they did not indicate whether the latter change was statistically significant.
The present study was designed to examine the in utero adenylate cyclase activity in individual fetal rabbit hearts from 21 to 3 1 days gestation. We have asked the question whether enzymatic activity parallels the ontogenetic pattern seen in myocardial P-adrenergic receptor density in this species. Fetal rabbits were chosen for these studies for three reasons. First, observations can be initiated on individual animals while they are still in utero. Second, it has been shown that, in fetal rabbits, significant myocardial norepinephrine stores and sympathetic innervation do not appear until very late in gestation and in the early neonatal period (9) . This could allow a developmental study of adenylate cyclase activity independent of external neuronal sympathetic input. Third, in order to clarify the question of species and gestational age differences regarding adenylate cyclase activity, there is a need for expanding the studies to include species and gestational ages that have not been examined to date. H ATJIS Preparation of heart homogenates. Time-dated, pregnant New Zealand White rabbits were sacrificed at 2 1, 25, 28, and 3 1 days gestation (term, 3 1 days). Intact hearts were removed from fetal rabbits and were either used fresh or immersed in liquid nitrogen and stored frozen at -70" C. No significant difference in enzymatic activity was noted between fresh and frozen tissue. On the day of the assay, the hearts were placed in 5 to 10 volumes/wet weight of ice-cold 0.9% NaCl (wt/vol) and 20 mM Tris-HC1 (buffer A), pH 7.5. They were then minced with scissors and homogenized with a Brinkmann Polytron (setting 6-7, 10 s). A crude membrane preparation was obtained from fetal hearts after centrifugation at 20,000 x g for 10 min (4" C) (1 1). The pellets were then resuspended in 2 ml of ice-cold buffer A and preincubated for 15 min at 30" C in the presence of 0.5 mM dithiothreitol, 0.17 mM EGTA, 1 mM HCl, 0.2% bovine serum albumin, 5 mM MgC12, pH 7.45. The suspension was then recentrifuged as previously outlined. The resulting pellets were resuspended in ice-cold buffer A (100-1 50 volumes/g wet weight) and used in the assay.
Adenylate cyclase assay. Adenylate cyclase activity was determined by measuring the conversion of [LU-~'P]ATP to [32P]~AMP and isolating the product by a modification of a method developed by Salomon et al. (22) . The reaction was camed out in duplicate or triplicate at 30" C for 10 min in a final volume of 0.2 ml containing 0.1 ml membrane fraction (5-20 pg of protein/ tube) and 50 mM Tris-HCI, pH 7.5,0.45% NaCl, 0.5 mM ATP, 5 mM MgC12, 0.17 mM EGTA, 0.05 mM CAMP, 0.5 mM dithiothreitol, 0.75 mM 3-isobutylmethylxanthine, 0.1 mg/ml creatine kinase, 10 mM creatine phosphate, and 1-2 x lo6 cpm of [cI-~~PIATP. Appropriate drugs were added as required. The reaction was initiated by adding the membrane fraction to the incubation tubes. It was linear with respect to time (20 min) and protein concentration. The reaction was terminated by the addition of 0.25 ml of a solution containing 50 mM Tris-HC1 (pH 7.5),5 mM ATP, 1 mM CAMP, and 5% sodium dodecyl sulfate. I3H]cAMP (10,000-1 5,000 cpm/tube) was added to all tubes to serve as an internal standard and monitor the efficiency of recovery. The tubes were then placed in boiling water for 10 min and then allowed to cool down to room temperature. [32P]cAMP was isolated using sequential Dowex (AG 50W-X4, 200-400 mesh, Bio-Rad) and neutral alumina columns essentially as described by Salomon et al. (22) and counted in a scintillation counter (Tracor-111). Recovery of cyclic AMP was determined by per cent recovery of [3H]cAMP external standard in each sample.
Results have been corrected for per cent recovery (routinely greater than 60%). Enzymatic activity was expressed as pmol 3'3'-CAMP produced/mg of protein/min (per heart). Kac, values of the enzyme for I-isoproterenol (concentration of l-isoproteren01 required to half-maximally stimulate enzymatic activity) was determined in some experiments by performing dose-response curves. Kac, was calculated by logit-log transformation of the data from each individual dose-response curve.
Protein assay. Protein concentrations were determined according to the method of Bradford using bovine serum albumin as a standard (4) .
Statistical analysis. We utilized analysis of variance to test the null hypotheses that, with advancing gestation, there is no difference in maximal adenylate cyclase stimulation by agonists or K,,, of enzyme by I-isoproterenol. A p value of less than 0.05 was considered significant. For multiple comparisons, analysis of variance with Scheffe's multiple range test was used.
RESULTS
In preliminary experiments, it was determined that basal adenylate cyclase activity at 21, 25, 28, and 31 days gestation was only minimally increased in the presence of GTP or I-isoproteren01 alone. However, when GTP was added in combination with 1-isoproterenol, there was a substantial rise in the level of adenylate cyclase activity with maximal stimulation occurring at a GTP concentration of 100 pM. Thus, in order to effect equivalent comparisons between basal versus stimulated enzymatic activity, in all subsequently reported experiments, GTP was present in a final concentration of 100 pM. In contrast, NaF stimulation was not dependent on the presence of GTP. Figure 1 shows basal adenylate cyclase activity in the presence of GTP and after stimulation by NaF and 1-isoproterenol. The inhibition of I-isoproterenol stimulated enzymatic activity by dlpropranolol is also shown. Basal activity did not change significantly with advancing gestation. However, in all cases, there was a substantial increase in the enzymatic activity secondary to NaF stimulation. The per cent increase, compared to baseline, was not different in the gestational ages studied. In contrast, maximal stimulation by 1-isoproterenol was significantly greater in the . . . . 25-, 28-, and 31-day gestation fetal myocardium than in the 21-day fetuses. Finally, I-isoproterenol-stimulated adenylate cyclase activity was specifically inhibited by dl-propranolol in all groups tested.
The relationship of adenylate cyclase stimulation by increasing I-isoproterenol concentrations, in the presence of GTP, is shown in Figure 2 . No significant differences were noted between 2 5 , 28-, and 3 1-day fetal hearts. However, there is a significant shift of the curve to the right when myocardial adenylate cyclase activity was studied in 21-day fetuses and compared to 25-31-day fetuses. Using logit-log transformation of the data, Kac, of the enzyme was calculated. Table 1 shows the K,,, values determined individually in myocardial membranes from 2 1-and 25-3 1-day gestation fetuses. There is a highly significant decrease in the K,,, value with advancing gestation when data from 21-and 25-3 1-day gestation fetuses are compared.
DISCUSSION
We have previously shown that there is a significant increase in P-adrenergic receptor concentration in fetal rabbit myocardial membranes from 21 to 3 1 days gestation. In contrast, the Ko of these 0-adrenergic receptors for '251-HYP and their K, for 1-isoproterenol did not show any developmental changes (1 I). Nor was there any change in our ability to detect a "high" and "low" affinity state of the receptor for I-isoproterenol in the absence or presence of GTP, respectively (12) . We have now examined adenylate cyclase activity in similarly prepared fetal rabbit myocardial membranes from 2 1 to 3 1 days gestation, thus providing new information on the ontogenesis of P-adrenoreceptorladenylate cyclase complex in this species.
Adenylate cyclase activity was detectable in fetal rabbit myocardial homogenates from single pups as early as 2 1 days gestation. This is the earliest time that this enzyme has been studied in this species. Basal enzymatic activity, in the presence of 100 pM GTP, did not change significantly with advancing gestation. Although the molecular explanation of basal adenylate cyclase activity is not well defined, it probably does not reflect the dynamic relationships between components of P-adrenoreceptorladenylate cyclase complex and exogenous stimulators. For these reasons, we have extended our observations to include stimulation of enzymatic activity by a non-P-adrenoreceptordependent drug (NaF) as well as a specific P-adrenoreceptor agonist, I-isoproterenol. We have found that NaF-stimulated activity was similar in all gestational ages studied and was independent of GTP. This is consistent with previous observations concerning the probable mode of action of NaF mediated directly through another component of P-adrenoreceptorladenylate cyclase complex, the so-called stimulatory nucleotide binding subunit (25). Since there was no significant difference in the degree of NaF-dependent enzymatic stimulation with advancing gestation, it appears that the function of this component, as indicated by the degree of NaF stimulation, does not undergo any significant maturational changes.
In contrast to NaF, P-adrenoreceptor-related adenylate cyclase activation is a GTP-dependent process in that I-isoproterenol required the presence of GTP in order to stimulate the enzyme. We showed that the extent of enzymatic stimulation by maximal concentrations of I-isoproterenol(100 pM) was more marked in older (25-3 1 -day gestation) than in the younger (2 1 -day gestation) rabbit fetal hearts. Finally, the sensitivity of the enzyme to I-isoproterenol stimulation, as indicated by the decrease in Ka,, values, increased substantially with advancing gestation (21-versus 25-3 1 -day gestation fetuses). These results are somewhat in conflict with previously reported observations in neonatal rats and term fetal sheep as well as fetal rabbits (3, 6, 23, 30) . It is conceivable that these contradictory findings may be attributed to different maturational profiles between species as well as the timing of tissue sampling (fetuses versus neonates, late gestation fetal sheep). An additional major point of difference between the previously reported rat (30) and rabbit (23) adenylate cyclase experiments and our studies is that they utilized pooled heart tissue from several animals of the same gestational or postnatal age while we studied individually prepared hearts. "Pooling" might have obscured intergroup as well as intragroup differences. Finally, the method of tissue preparation might have contributed to these discrepancies. In some adenylate cyclase studies, investigators have used either relatively crude myocardial membranes (8) or crude homogenates (19) . Although a crude membrane preparation was used in our experiments, we tried to prepare heart membranes in a manner similar to that we reported in our P-adrenoreceptor studies (1 1, 12 ). This is an important consideration if P-adrenoreceptor properties are to be directly correlated with adenylate cyclase activity.
The developmental changes in per cent maximal adenylate cyclase stimulation by I-isoproterenol reported in this communication are consistent with our observations on the density of myocardial P-adrenoreceptors in this species (1 1). However, the observation that K,,, of the enzyme by 1-isoproterenol decreases as the fetus approaches term suggests that there might be an increase in the sensitivity of the enzyme. The etiology for this latter change is not clear. However, it does not appear to involve an alteration in the interaction of fetal myocardial P-adrenoreceptors with I-isoproterenol in the presence of GTP (12) . Further work in this area is warranted to elucidate the molecular stoichiometry of these changes.
Finally, these results on P-ARladenylate cyclase maturation with advancing gestation, could, at least partially, account for the observed developmental changes in myocardial contractility and heart rate responses. It is noteworthy that the maturation of the P-ARlcyclase complex in this species occurs at a time that sympathetic neuronal input at the myocardial level is virtually nonexistent (9) ABSTRACT. The effects of fetal acidosis (mean pH 6.93) on fetal and maternal blood coagulation were measured.
Test results from 10 fetal lambs and mother ewes (127 + 2 days mean gestation) before and after fetal lactic acid infusions were compared to test results from eight control fetal lambs and mother ewes (127 + 3 days mean gestation) before and after control glucose infusion. Significant changes found in acidotic fetal lambs not seen in control fetuses included an increase in the white blood cell count (mean 2800/mm3 before to 3600/mm3 after acidosis; p = 0.0009), a shortening of the thrombin time (mean 17.8 s before to 11.2 s after acidosis; p = 0.0001), and decreases in the activities of factor V (mean 57% before to 37% after acidosis; p = 0.0014) and factor IX (mean 35% before to 29% after acidosis;~ = 0.0128). There was also a reduction in the concentration of fibrinogen (mean 147 mg/100 ml before to 125 mg/100 ml after acidosis;~ = 0.0492) but no significant changes in the levels of fibrin monomer, fibrin-ogenlfibrin degradation products, or antithrombin 111. I n vitro exposure of five different fetal whole blood samples to a pH of 6.9 for 2 h at 37" C did not result in significant changes in any of the coagulation factor activities. A significant decrease in the level of factor V was also found in the mother ewes of the acidotic fetuses (mean 141 % before to 113% after acidosis; p = 0.006) and a decrease in the level of maternal factor IX approached significance (mean 119% before to 102% after acidosis; p = 0.0564). Two hours of severe fetal lactic acidosis induces changes in blood coagulation, but not the usual findings of disseminated intravascular coagulation. Corresponding decreases in factor V and IX activities in the mothers of acidotic fetal lambs suggest the liberation of a mediator capable of crossing the placenta and influencing maternal coagulation.
(Pediatr Res 19: 78-82, 1985) Significant acidosis is likely to occur in the fetus in association with placental infarction, cord compression, or,partial abruption. Acidosis may also be present in association with hypoxia in
